CERo Therapeutics Holdings, Inc.

CERO Stock Healthcare Biotechnology
$0.01
+0.00 (+6.00%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+5.7%
3 Months
-39.6%
YTD
-84.2%
1 Year
-99.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
205.7%
Largest decline max drawdown, since Aug 2025
-99.9%
Risk-adjusted return Sharpe ratio, 1-year
-1.50

Own CERO?

See how CERO contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.